License Agreements
Biotechnology
Biotechnology (2,718) | License Agreements (8,885)
- 2seventy bio, Inc. (4 contracts)
- 4D Molecular Therapeutics Inc (4)
- 89bio, Inc. (1)
- ABEONA THERAPEUTICS INC. (6)
- ACADIA PHARMACEUTICALS INC (7)
- ACCELERON PHARMA INC (2)
- Accustem Sciences Inc. (1)
- Achaogen, Inc. (6)
- ACHIEVE LIFE SCIENCES, INC. (3)
- Acorda Therapeutics (23)
- Actinium Pharmaceuticals, Inc. (4)
- Acumen Pharmaceuticals, Inc. (1)
- Adagio Therapeutics, Inc. (2)
- Adamas Pharmaceuticals Inc (2)
- Adhera Therapeutics, Inc. (15)
- ADiTx Therapeutics, Inc. (1)
- ADMA BIOLOGICS, INC. (2)
- ADURO BIOTECH, INC. (16)
- Advaxis, Inc. (5)
- Adverum Biotechnologies, Inc. (12)
- Aeglea BioTherapeutics, Inc. (6)
- AGENUS INC (20)
- AGIOS PHARMACEUTICALS INC (2)
- Aimmune Therapeutics, Inc. (1)
- AKCEA THERAPEUTICS, INC. (2)
- Akebia Therapeutics, Inc. (5)
- Akouos, Inc. (1)
- ALBIREO PHARMA, INC. (6)
- Aldeyra Therapeutics, Inc. (3)
- Alexion Pharmaceuticals (1)
- Aligos Therapeutics, Inc. (4)
- Alkermes plc. (10)
- Allakos Inc. (6)
- Allarity Therapeutics, Inc. (15)
- Allena Pharmaceuticals, Inc. (2)
- Alliqua BioMedical, Inc. (5)
- Allogene Therapeutics, Inc. (1)
- Allovir, Inc. (3)
- ALNYLAM PHARMACEUTICALS, INC. (5)
- Alpha Healthcare Acquisition Corp. (10)
- ALPINE IMMUNE SCIENCES, INC. (5)
- Altimmune, Inc. (9)
- AMARILLO BIOSCIENCES INC (1)
- AMARIN CORP PLC (4)
- Amgen Inc. (2)
- AMICUS THERAPEUTICS, INC. (7)
- AmpliPhi Biosciences Corp (2)
- ANAPTYSBIO INC (2)
- Anika Therapeutics (3)
- Anixa Biosciences Inc (6)
- Annovis Bio, Inc. (3)
- Apellis Pharmaceuticals, Inc. (2)
- APPLIED GENETIC TECHNOLOGIES CORP (12)
- Applied Therapeutics Inc. (2)
- Aptevo Therapeutics Inc. (3)
- Aptose Biosciences Inc. (1)
- AQUINOX PHARMACEUTICALS, INC (3)
- Aravive, Inc. (6)
- Arbutus Biopharma Corp (7)
- ARCA biopharma, Inc. (10)
- Arcellx, Inc. (1)
- Arcus Biosciences, Inc. (7)
- Arcutis Biotherapeutics, Inc. (3)
- ARDELYX, INC. (9)
- ARENA PHARMACEUTICALS INC (3)
- Aridis Pharmaceuticals, Inc. (5)
- ARROWHEAD PHARMACEUTICALS, INC. (8)
- Arsanis, Inc. (11)
- Artiva Biotherapeutics, Inc. (7)
- ARYA Sciences Acquisition Corp II (1)
- ASSEMBLY BIOSCIENCES, INC. (4)
- Atara Biotherapeutics, Inc. (14)
- Athenex, Inc. (37)
- ATHERSYS, INC (5)
- ATOSSA GENETICS INC (7)
- Atreca, Inc. (2)
- Aura Biosciences, Inc. (3)
- AVEO PHARMACEUTICALS INC (10)
- Avid Bioservices, Inc. (6)
- AVROBIO, Inc. (9)
- Axovant Sciences Ltd. (4)
- Ayala Pharmaceuticals, Inc. (3)
- AZIYO BIOLOGICS, INC. (2)
- AzurRx BioPharma, Inc. (2)
- Beam Therapeutics Inc. (8)
- BeiGene, Ltd. (1)
- BELLICUM PHARMACEUTICALS, INC (9)
- BICYCLE THERAPEUTICS Ltd (1)
- BIO-PATH HOLDINGS INC (2)
- bioAffinity Technologies, Inc. (1)
- BioAtla, Inc. (4)
- BioCardia, Inc. (1)
- BIOCRYST PHARMACEUTICALS INC (4)
- Biohaven Pharmaceutical Holding Co Ltd. (8)
- BioLife4D Corp (4)
- BIOMARIN PHARMACEUTICAL INC (8)
- BioRestorative Therapies, Inc. (3)
- BIOSPECIFICS TECHNOLOGIES CORP (7)
- Biostage, Inc. (2)
- BIOTIME INC (19)
- BIOXYTRAN, INC (3)
- Blue Water Vaccines Inc. (8)
- bluebird bio, Inc. (20)
- Blueprint Medicines Corp (1)
- Bone Biologics Corp (7)
- BRAINSTORM CELL THERAPEUTICS INC. (1)
- BriaCell Therapeutics Corp. (1)
- BridgeBio Pharma, Inc. (6)
- BullFrog AI Holdings, Inc. (9)
- BURZYNSKI RESEARCH INSTITUTE INC (1)
- C4 Therapeutics, Inc. (3)
- Cabaletta Bio, Inc. (3)
- CALADRIUS BIOSCIENCES, INC. (5)
- Calithera Biosciences, Inc. (1)
- Calyxt, Inc. (3)
- Candel Therapeutics, Inc. (5)
- CAPRICOR THERAPEUTICS, INC. (13)
- Capstone Therapeutics Corp. (6)
- CareDx, Inc. (2)
- Caribou Biosciences, Inc. (8)
- CASI Pharmaceuticals, Inc. (7)
- CASTLE BIOSCIENCES INC (1)
- CATALYST BIOSCIENCES, INC. (30)
- CATALYST PHARMACEUTICALS, INC. (10)
- Celcuity Inc. (2)
- Cell Source, Inc. (4)
- Celldex Therapeutics, Inc. (7)
- Cellectar Biosciences, Inc. (1)
- Cellular Biomedicine Group, Inc. (4)
- Centessa Pharmaceuticals Ltd (4)
- Century Therapeutics, Inc. (8)
- CEREBAIN BIOTECH CORP. (1)
- Chanticleer Holdings, Inc. (3)
- Chardan Healthcare Acquisition 2 Corp. (1)
- Chardan Healthcare Acquisition Corp. (4)
- Checkmate Pharmaceuticals, Inc. (1)
- Checkpoint Therapeutics, Inc. (5)
- CHIMERIX INC (4)
- Cidara Therapeutics, Inc. (1)
- CLEVELAND BIOLABS INC (4)
- CM Life Sciences III Inc. (2)
- CohBar, Inc. (2)
- Coherus BioSciences, Inc. (10)
- Conatus Pharmaceuticals Inc. (6)
- CONCERT PHARMACEUTICALS, INC. (2)
- Consonance-HFW Acquisition Corp. (1)
- CONTRAFECT Corp (2)
- Corbus Pharmaceuticals Holdings, Inc. (3)
- Cortexyme, Inc. (3)
- Corvus Pharmaceuticals, Inc. (3)
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (2)
- Crinetics Pharmaceuticals, Inc. (1)
- CTI BIOPHARMA CORP (4)
- Cue Biopharma, Inc. (14)
- Cullinan Oncology, LLC (3)
- Curative Biotechnology Inc (17)
- CURIS INC (2)
- Cyclacel Pharmaceuticals, Inc. (7)
- Cyclerion Therapeutics, Inc. (1)
- CytoDyn Inc. (2)
- Cytokinetics, Incorporated (1)
- CytomX Therapeutics, Inc. (5)
- CYTORI THERAPEUTICS, INC. (6)
- CYTRX CORP (2)
- Day One Biopharmaceuticals Holding Co LLC (3)
- Decibel Therapeutics, Inc. (8)
- Deciphera Pharmaceuticals, Inc. (1)
- Denali Therapeutics Inc. (1)
- Dermavant Sciences Ltd (10)
- Dermira, Inc. (3)
- Design Therapeutics, Inc. (1)
- Dicerna Pharmaceuticals Inc (4)
- Diffusion Pharmaceuticals Inc. (4)
- Digital Development Partners, Inc. (1)
- DYADIC INTERNATIONAL INC (2)
- Dynamics Special Purpose Corp. (4)
- DYNAVAX TECHNOLOGIES CORP (1)
- Dyne Therapeutics, Inc. (1)
- Eagle Pharmaceuticals, Inc. (11)
- Edge Therapeutics, Inc. (2)
- Editas Medicine, Inc. (8)
- Eidos Therapeutics, Inc. (1)
- Eiger BioPharmaceuticals, Inc. (13)
- Elevation Oncology, Inc. (2)
- Emerald Bioscience, Inc. (9)
- Emergent BioSolutions Inc. (1)
- Enanta Pharmaceuticals, Inc. (1)
- Enochian Biosciences Inc (2)
- Entrada Therapeutics, Inc. (2)
- ENZOLYTICS INC (1)
- Epizyme, Inc. (2)
- Erasca, Inc. (4)
- Esperion Therapeutics, Inc. (1)
- Evelo Biosciences, Inc. (6)
- EXACT SCIENCES CORP (15)
- Exelixis (5)
- EXICURE, INC. (13)
- FATE THERAPEUTICS INC (17)
- FENNEC PHARMACEUTICALS INC. (1)
- Fibrocell Science, Inc. (3)
- FIBROGEN INC (8)
- Finch Therapeutics Group, Inc. (4)
- FIVE PRIME THERAPEUTICS INC (12)
- Flex Pharma, Inc. (7)
- Flexion Therapeutics Inc (2)
- FLUOROPHARMA MEDICAL, INC. (2)
- Forma Therapeutics Holdings, Inc., (2)
- Fortress Biotech, Inc. (1)
- Frequency Therapeutics, Inc. (3)
- FS Development Corp. (5)
- Fusion Pharmaceuticals Inc. (2)
- G1 Therapeutics, Inc. (2)
- GALECTIN THERAPEUTICS INC (1)
- Gemphire Therapeutics Inc. (3)
- Gene Biotherapeutics, Inc. (11)
- GENELUX CORP (4)
- Generation Bio Co. (4)
- GENOCEA BIOSCIENCES, INC. (2)
- Genprex, Inc. (9)
- GeoVax Labs, Inc. (5)
- GERON CORP (6)
- Gilead Sciences (11)
- Global Blood Therapeutics, Inc. (2)
- GLYCOMIMETICS INC (2)
- GOLDENWELL BIOTECH, INC. (2)
- Gossamer Bio, Inc. (3)
- Grail, Inc. (5)
- Graphite Bio, Inc. (7)
- Greater Cannabis Company, Inc. (1)
- Greenwich LifeSciences, Inc. (3)
- Gritstone Oncology, Inc. (3)
- GT Biopharma, Inc. (17)
- GTX INC (21)
- HARBOR DIVERSIFIED, INC. (4)
- Harpoon Therapeutics, Inc. (3)
- HCW Biologics Inc. (1)
- Health Sciences Acquisitions Corp (2)
- HEAT BIOLOGICS, INC. (32)
- HedgePath Pharmaceuticals, Inc. (5)
- HilleVax, Inc. (1)
- HISTOGENICS CORP (16)
- Homology Medicines, Inc. (5)
- HOOKIPA Pharma Inc. (2)
- HUMANIGEN, INC (1)
- iBio, Inc. (5)
- Icosavax, Inc. (6)
- IDEAYA Biosciences, Inc. (4)
- IDERA PHARMACEUTICALS, INC. (5)
- Immix Biopharma, Inc. (2)
- IMMUCELL CORP (2)
- IMMUNE PHARMACEUTICALS INC (7)
- Immune Therapeutics, Inc. (8)
- ImmunoCellular Therapeutics, Ltd. (11)
- IMMUNOGEN INC (14)
- Immunome Inc. (2)
- IMMUNOMEDICS INC (3)
- IN8BIO, INC. (8)
- Incyte (4)
- INFINITY PHARMACEUTICALS, INC. (5)
- Inhibikase Therapeutics, Inc. (1)
- Inhibrx, Inc. (7)
- Inmune Bio, Inc. (9)
- Innovation Pharmaceuticals Inc. (1)
- INOVIO PHARMACEUTICALS, INC. (3)
- Inozyme Pharma, Inc. (1)
- INSMED Inc (6)
- Intellia Therapeutics, Inc. (12)
- INTERCEPT PHARMACEUTICALS, INC. (9)
- International Stem Cell CORP (9)
- INTREXON CORP (1)
- Intrinsic Medicine, Inc. (7)
- IONIS PHARMACEUTICALS INC (21)
- IOVANCE BIOTHERAPEUTICS, INC. (3)
- IRONWOOD PHARMACEUTICALS INC (9)
- Isoray, Inc. (11)
- Janux Therapeutics, Inc. (1)
- Jounce Therapeutics, Inc. (2)
- Kadmon Holdings, Inc. (2)
- KalVista Pharmaceuticals, Inc. (1)
- Karuna Therapeutics, Inc. (3)
- Karyopharm Therapeutics Inc. (4)
- Keros Therapeutics, Inc. (3)
- Kezar Life Sciences, Inc. (2)
- Kiniksa Pharmaceuticals, Ltd. (4)
- Kiromic Biopharma, Inc. (4)
- Kura Oncology, Inc. (9)
- LA JOLLA PHARMACEUTICAL CO (2)
- Lantern Pharma Inc. (6)
- LEAP THERAPEUTICS, INC. (3)
- LEXICON PHARMACEUTICALS, INC. (1)
- LianBio (19)
- LifeSci Acquisition Corp. (1)
- Ligand Pharmaceuticals Incorporated (23)
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
- Locust Walk Acquisition Corp. (1)
- LogicBio Therapeutics, Inc. (5)
- LONGEVERON LLC (5)
- Lyell Immunopharma, Inc. (1)
- MACROGENICS INC (4)
- MADRIGAL PHARMACEUTICALS, INC. (2)
- Magenta Therapeutics, Inc. (6)
- MAIA Biotechnology, Inc. (6)
- MANHATTAN SCIENTIFICS INC (1)
- Marker Therapeutics, Inc. (2)
- MATEON THERAPEUTICS INC (8)
- Matinas BioPharma Holdings, Inc. (1)
- MEDICINOVA INC (8)
- MEI Pharma, Inc. (6)
- MeiraGTx Holdings plc (9)
- MERRIMACK PHARMACEUTICALS INC (1)
- Mersana Therapeutics, Inc. (7)
- Merus N.V. (1)
- Metacrine, Inc. (1)
- Millendo Therapeutics, Inc. (11)
- MiMedx Group, Inc. (10)
- Minerva Neurosciences, Inc. (8)
- MiNK Therapeutics, Inc. (1)
- MIRAGEN THERAPEUTICS, INC. (13)
- Mirum Pharmaceuticals, Inc. (7)
- Molecular Templates, Inc. (6)
- Moleculin Biotech, Inc. (13)
- Momenta Pharmaceuticals, Inc. (2)
- Monopar Therapeutics (10)
- Monte Rosa Therapeutics, Inc. (1)
- Morphic Holding, Inc. (2)
- MUSTANG BIO, INC. (6)
- Myovant Sciences Ltd. (2)
- Myriad Genetics, Inc. (2)
- NANOVIRICIDES, INC. (3)
- NantKwest, Inc. (12)
- Natera, Inc. (1)
- NAVIDEA BIOPHARMACEUTICALS, INC. (4)
- NEUROBIOLOGICAL TECHNOLOGIES INC (5)
- NEUROCRINE BIOSCIENCES INC (2)
- NEUROTROPE BIOSCIENCE, INC. (3)
- Neurotrope, Inc. (1)
- NEWLINK GENETICS CORP (45)
- NexImmune, Inc. (1)
- NextCure, Inc. (2)
- Nkarta, Inc. (1)
- NOVAVAX INC (8)
- Novus Therapeutics, Inc. (3)
- NTN BUZZTIME INC (4)
- Nuo Therapeutics, Inc. (7)
- Nuvectis Pharma, Inc. (4)
- Ohr Pharmaceutical Inc (2)
- Omega Therapeutics, Inc. (4)
- OncoCyte Corp (4)
- Oncorus, Inc. (7)
- ONCOSEC MEDICAL Inc (1)
- Ophthotech Corp. (7)
- Opko Health, Inc. (12)
- ORAGENICS INC (10)
- Orchard Therapeutics plc (1)
- Organogenesis Holdings Inc. (1)
- ORGANOVO HOLDINGS, INC. (5)
- Oric Pharmaceuticals, Inc. (1)
- Outlook Therapeutics, Inc. (3)
- Ovid Therapeutics Inc. (4)
- Oyster Point Pharma, Inc. (1)
- PALATIN TECHNOLOGIES INC (2)
- PepGen Inc. (1)
- Pfenex Inc. (13)
- PharmaCyte Biotech, Inc. (3)
- PhaseBio Pharmaceuticals Inc (7)
- PIERIS PHARMACEUTICALS, INC. (7)
- PLURISTEM THERAPEUTICS INC (2)
- POLARITYTE, INC. (3)
- PORTOLA PHARMACEUTICALS INC (1)
- Poseida Therapeutics, Inc. (10)
- Praxis Precision Medicines, Inc. (2)
- PRECISION BIOSCIENCES INC (7)
- Prelude Therapeutics Inc (2)
- PREMIER BIOMEDICAL INC (6)
- Prevail Therapeutics Inc. (2)
- Principia Biopharma Inc. (5)
- Progenics Pharmaceuticals, Inc. (9)
- Prometheus Biosciences, Inc. (5)
- Protagenic Therapeutics, Inc. (3)
- Protagonist Therapeutics, Inc (1)
- Protalix BioTherapeutics, Inc. (7)
- PROTEON THERAPEUTICS INC (3)
- PROTEOSTASIS THERAPEUTICS, INC. (6)
- Prothena Corp plc (12)
- PTC THERAPEUTICS, INC. (3)
- PUMA BIOTECHNOLOGY, INC. (14)
- Pyxis Oncology, Inc. (6)
- Q BioMed Inc. (3)
- Qrons Inc. (4)
- Radius Health, Inc. (5)
- Rallybio Corp (4)
- RECURSION PHARMACEUTICALS, INC. (3)
- Regeneron Pharmaceuticals (11)
- REGENERX BIOPHARMACEUTICALS INC (3)
- REGENXBIO Inc. (33)
- Regulus Therapeutics Inc. (1)
- Reneo Pharmaceuticals, Inc. (1)
- Repare Therapeutics Inc. (1)
- Retrophin, Inc. (2)
- REXAHN PHARMACEUTICALS, INC. (5)
- Rezolute, Inc. (6)
- RHYTHM PHARMACEUTICALS, INC. (5)
- RIGEL PHARMACEUTICALS INC (3)
- RITTER PHARMACEUTICALS INC (12)
- ROCKET PHARMACEUTICALS, INC. (1)
- Rubius Therapeutics, Inc. (1)
- Sage Therapeutics, Inc. (3)
- Sana Biotechnology, Inc. (34)
- SANGAMO THERAPEUTICS, INC (14)
- Sarepta Therapeutics, Inc. (7)
- Savara Inc (5)
- SEATTLE GENETICS INC (9)
- SELECTA BIOSCIENCES INC (5)
- SELLAS Life Sciences Group, Inc. (37)
- Sensei Biotherapeutics, Inc. (1)
- Seres Therapeutics, Inc. (2)
- Sesen Bio, Inc. (6)
- Shattuck Labs, Inc. (1)
- Sierra Oncology, Inc. (5)
- Sigilon Therapeutics, Inc. (7)
- Silverback Therapeutics, Inc. (4)
- Social Capital Suvretta Holdings Corp. III (1)
- Solid Biosciences Inc. (12)
- SOLIGENIX, INC. (2)
- SOPHIRIS BIO INC. (4)
- Sorrento Therapeutics, Inc. (13)
- Spectrum Pharmaceuticals, Inc. (11)
- Spero Therapeutics, Inc. (8)
- SPHERIX INC (5)
- Spring Bank Pharmaceuticals, Inc. (1)
- SpringWorks Therapeutics, Inc. (2)
- SPRUCE BIOSCIENCES, INC. (1)
- SQZ Biotechnologies Co (1)
- Stellar Biotechnologies, Inc. (8)
- Stoke Therapeutics, Inc. (4)
- Sun BioPharma, Inc. (4)
- SUNESIS PHARMACEUTICALS INC (3)
- Sunshine Biopharma, Inc (2)
- Surface Oncology, Inc. (3)
- SUTRO BIOPHARMA, INC. (3)
- Syndax Pharmaceuticals Inc (15)
- SYNLOGIC, INC. (16)
- Synthetic Biologics, Inc. (10)
- Syros Pharmaceuticals, Inc. (2)
- T2 Biosystems, Inc. (1)
- Talaris Therapeutics, Inc. (1)
- Taysha Gene Therapies, Inc. (3)
- TENAX THERAPEUTICS, INC. (8)
- Tenaya Therapeutics, Inc. (1)
- TG THERAPEUTICS, INC. (3)
- Therapeutics Acquisition Corp. (2)
- Tocagen Inc (4)
- Tonix Pharmaceuticals Holding Corp. (6)
- Tracon Pharmaceuticals, Inc. (7)
- Transcode Therapeutics, Inc. (2)
- Translate Bio, Inc. (2)
- TREVENA INC (1)
- Trovagene, Inc. (2)
- TScan Therapeutics, Inc. (3)
- Turning Point Therapeutics, Inc. (3)
- U.S. Stem Cell, Inc. (2)
- Ultragenyx Pharmaceutical Inc. (18)
- Unicycive Therapeutics, Inc. (3)
- uniQure N.V. (5)
- United Therapeutics Corp (4)
- Unity Biotechnology, Inc. (29)
- Unum Therapeutics Inc. (1)
- UroGen Pharma Ltd. (1)
- VACCINEX, INC. (2)
- Vaccitech plc (4)
- Vanda Pharmaceuticals Inc. (11)
- Vaxart, Inc. (1)
- Vaxcyte, Inc. (1)
- Vaxxinity, Inc. (1)
- VBI Vaccines Inc (1)
- Vera Therapeutics, Inc. (4)
- Verastem, Inc. (3)
- Vericel Corp (6)
- Vertex Pharmaceuticals Inc (2)
- Verve Therapeutics, Inc. (2)
- VICAL INC (20)
- Vicapsys Life Sciences, Inc. (1)
- Viela Bio, Inc. (2)
- Vigil Neuroscience, Inc. (1)
- Viking Therapeutics, Inc. (3)
- Vir Biotechnology, Inc. (14)
- Virios Therapeutics, LLC (1)
- VistaGen Therapeutics, Inc. (8)
- VITAL THERAPIES INC (1)
- Vor Biopharma Inc. (4)
- Voyager Therapeutics, Inc. (5)
- vTv Therapeutics Inc. (10)
- Werewolf Therapeutics, Inc. (1)
- WINDTREE THERAPEUTICS INC (5)
- XBiotech Inc. (1)
- Xencor Inc (8)
- Xenetic Biosciences, Inc. (7)
- Xenon Pharmaceuticals Inc. (5)
- Xilio Therapeutics, Inc. (2)
- XOMA Corp (18)
- Y-mAbs Therapeutics, Inc. (4)
- YIELD10 BIOSCIENCE, INC. (1)
- Yulong Eco-Materials Ltd (2)
- ZAFGEN, INC. (8)
- Zai Lab Ltd (5)
- Zentalis Pharmaceuticals, LLC (3)
- ZIOPHARM ONCOLOGY INC (9)
- License Agreement, dated May 22, 2023, by and between the Company and Dr. Stanislaw R. Burzynski (BURZYNSKI RESEARCH INSTITUTE INC, Filed With SEC on May 22, 2023)
- Know-How License Agreement between Viewpoint Molecular Targeting, Inc. and Mayo Foundation For Medical Education and Research, dated February 22. 2022 (Isoray, Inc., Filed With SEC on May 15, 2023)
- Amendment #4 to the Exclusive License Agreement between Viewpoint Molecular Targeting, Inc. and the University of Iowa Research Foundation, dated Jund 11, 2020 (Isoray, Inc., Filed With SEC on May 15, 2023)
- Amendment #3 to the Exclusive License Agreement between Viewpoint Molecular Targeting, Inc. and the University of Iowa Research Foundation, dated January 30, 2020 (Isoray, Inc., Filed With SEC on May 15, 2023)
- Amendment #2 to the Exclusive License Agreement between Viewpoint Molecular Targeting, Inc. and the University of Iowa Research Foundation, dated November 13, 2019 (Isoray, Inc., Filed With SEC on May 15, 2023)
- Amendment #1 to the Exclusive License Agreement between Viewpoint Molecular Targeting, Inc. and the University of Iowa Research Foundation, dated July 31, 2018 (Isoray, Inc., Filed With SEC on May 15, 2023)
- Exclusive License Agreement between Viewpoint Molecular Targeting, Inc. and the University of Iowa Research Foundation, dated June 5, 2018 (Isoray, Inc., Filed With SEC on May 15, 2023)
- Second Amendment, dated as of March 13, 2023, to the License Agreement, by and between the University of Florida Research Foundation, Inc. and the Registrant (Decibel Therapeutics, Inc., Filed With SEC on May 15, 2023)
- Amended and Restated Exclusive License Agreement, dated as of March 10, 2023, by and between the Curators of the University of Missouri and the Registrant (Decibel Therapeutics, Inc., Filed With SEC on May 15, 2023)
- Strategic Partnership and License Agreement, dated August 13, 2021, by and between NovaRock Biotherapeutics Ltd. and Flame Biosciences, Inc (LEAP THERAPEUTICS, INC., Filed With SEC on May 15, 2023)
- Patent & Technology License Agreement, dated November 18, 2022, between the Company and the University of Texas Health Science Center at San Antonio (Blue Water Vaccines Inc., Filed With SEC on May 12, 2023)
- NRC Technology License Amendment 5 (ORAGENICS INC, Filed With SEC on May 12, 2023)
- Inspirevax License Agreement (ORAGENICS INC, Filed With SEC on May 12, 2023)
- Amendment No.2, dated as of November 17, 2015, to Option and License Agreement, dated August 27, 2012, as amended April 18, 2014, by and between EIP Pharma LLC and Vertex... (Diffusion Pharmaceuticals Inc., Filed With SEC on May 11, 2023)
- Amendment No.1, dated as of April 8, 2014, to Option and License Agreement, dated August 27, 2012, by and between EIP Pharma LLC and Vertex Pharmaceuticals Incorporated (Diffusion Pharmaceuticals Inc., Filed With SEC on May 11, 2023)
- Option and License Agreement, dated as of August 27, 2012, by and between EIP Pharma LLC and Vertex Pharmaceuticals Incorporated (Diffusion Pharmaceuticals Inc., Filed With SEC on May 11, 2023)
- License Agreement by and between bluebird bio, Inc. and Institut Pasteur, dated September 8, 2011, as amended (2seventy bio, Inc., Filed With SEC on May 10, 2023)
- Agreement Regarding Payment of Royalties and Amendment to the Amended and Restated Exclusive License, by and between The Board of Trustees of the Leland Stanford Junior University... (CareDx, Inc., Filed With SEC on May 10, 2023)
- License, Development and Commercialization Agreement, dated July 9, 2015, by and between Mersana Therapeutics, Inc. and Recepta Biopharma S.A (Mersana Therapeutics, Inc., Filed With SEC on May 9, 2023)
- Amendment No. 3 to Option and License Agreement by and between the Company and Beam Therapeutics Inc., dated as of March 17, 2023 (Sana Biotechnology, Inc., Filed With SEC on May 8, 2023)
- Amendment to Exclusive License Agreement, dated April 11, 2023, between GeoVax, Inc. and City of Hope (GeoVax Labs, Inc., Filed With SEC on May 4, 2023)
- HTT Research, Development, Option and License Agreement among the Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., dated as of April. 8, 2013 (IONIS PHARMACEUTICALS INC, Filed With SEC on May 3, 2023)
- First Deed of Variation to License Agreement with UCL Business Limited dated March 30, 2022 (RITTER PHARMACEUTICALS INC, Filed With SEC on May 2, 2023)
- Amendment 1 to the Exclusive License Agreement (RAS), by and between Qualigen, Inc. and University of Louisville Research Foundation, Inc., dated March 16, 2021 (RITTER PHARMACEUTICALS INC, Filed With SEC on May 2, 2023)
- Exclusive License Agreement between the Company and University of Louisville Research Foundation (RAS), Inc., dated as of July 17, 2020 (RITTER PHARMACEUTICALS INC, Filed With SEC on May 2, 2023)
- Amendment 2 to the Exclusive License Agreement (QN-247), by and between Qualigen, Inc. and University of Louisville Research Foundation, Inc., dated January 17, 2023 (RITTER PHARMACEUTICALS INC, Filed With SEC on May 2, 2023)
- Amendment 1 to the Exclusive License Agreement (QN-247), by and between Qualigen, Inc. and University of Louisville Research Foundation, Inc., dated March 16, 2021 (RITTER PHARMACEUTICALS INC, Filed With SEC on May 2, 2023)
- License and Option Agreement dated as of February 28, 2023 by and between ImmunoGen, Inc. and Vertex Pharmaceuticals Incorporated (IMMUNOGEN INC, Filed With SEC on April 28, 2023)
- Agreement Amendment No. 2, dated as of July 31, 2009, to the License Agreement by and among Elan Pharmaceutical Research Corp., d/b/a Nanosystems and Elan Pharma International... (Alkermes plc., Filed With SEC on April 26, 2023)
- License Agreement by and among Elan Pharmaceutical Research Corp., d/b/a Nanosystems and Elan Pharma International Limited and Janssen Pharmaceutica N.V. dated as of March 31, 1999 (Alkermes plc., Filed With SEC on April 26, 2023)
- Second Amendment to Exclusive License Agreement by and between the University of Pittsburgh of the Commonwealth system of Higher Education and Immune Ventures, LLC dated April 17,... (Inmune Bio, Inc., Filed With SEC on April 20, 2023)
- First Amendment to Exclusive License Agreement between INmune Bio Inc. and Immune Ventures LLC dated April 17, 2023 (Inmune Bio, Inc., Filed With SEC on April 20, 2023)
- Amendment No. 3 to License Agreement between the Company and Statera Biopharma, Inc. dated April 15, 2023 (Immune Therapeutics, Inc., Filed With SEC on April 20, 2023)
- License Agreement dated April 6, 2023 (DYADIC INTERNATIONAL INC, Filed With SEC on April 12, 2023)
- License Agreement between the Company and Karveer (NANOVIRICIDES, INC., Filed With SEC on March 31, 2023)
- Second Amendment to License, Development and Supply Agreement, dated as of January 1, 2022, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Spectrum Pharmaceuticals, Inc., Filed With SEC on March 31, 2023)
- First Amendment to License, Development and Supply Agreement, dated as of February 28, 2018, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Spectrum Pharmaceuticals, Inc., Filed With SEC on March 31, 2023)
- License, Development and Supply Agreement, dated as of October 8, 2014, by and between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd (Spectrum Pharmaceuticals, Inc., Filed With SEC on March 31, 2023)
- Second Amendment to License and Distribution Agreement, dated September 22, 2022, by and between Biomet Biologics, LLC (BioCardia, Inc., Filed With SEC on March 29, 2023)
- License Agreement dated as of December 30, 2022 by and between Merck KGaA, Darmstadt, Germany and PDS Biotechnology Corporation (Edge Therapeutics, Inc., Filed With SEC on March 28, 2023)